{"id":"https://openalex.org/W2017441286","doi":"https://doi.org/10.1038/clpt.2010.207","title":"Conditional Approval and Approval Under Exceptional Circumstances as Regulatory Instruments for Stimulating Responsible Drug Innovation in Europe","display_name":"Conditional Approval and Approval Under Exceptional Circumstances as Regulatory Instruments for Stimulating Responsible Drug Innovation in Europe","publication_year":2010,"publication_date":"2010-10-20","ids":{"openalex":"https://openalex.org/W2017441286","doi":"https://doi.org/10.1038/clpt.2010.207","mag":"2017441286","pmid":"https://pubmed.ncbi.nlm.nih.gov/20962774"},"language":"en","primary_location":{"id":"doi:10.1038/clpt.2010.207","doi":"https://doi.org/10.1038/clpt.2010.207","is_oa":true,"landing_page_url":"https://doi.org/10.1038/clpt.2010.207","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/clpt.2010.207","source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology &amp; Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/clpt.2010.207","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090216644","display_name":"Wouter Boon","orcid":"https://orcid.org/0000-0003-1218-193X","observed_orcids":["https://orcid.org/0000-0003-1218-193X"]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"W P C Boon","raw_affiliation_strings":["Innovation Studies Group, Utrecht University, Utrecht, The Netherlands. w.boon@geo.uu.nl","Innovation Studies Group Utrecht University, Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Innovation Studies Group, Utrecht University, Utrecht, The Netherlands. w.boon@geo.uu.nl","institution_ids":["https://openalex.org/I193662353"]},{"raw_affiliation_string":"Innovation Studies Group Utrecht University, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I193662353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018830195","display_name":"Ellen H.M. Moors","orcid":"https://orcid.org/0000-0002-9724-5308","observed_orcids":["https://orcid.org/0000-0002-9724-5308"]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"E H M Moors","raw_affiliation_strings":["Innovation Studies Group Utrecht University, Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Innovation Studies Group Utrecht University, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I193662353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084778347","display_name":"Albert Jacob Meijer","orcid":"https://orcid.org/0000-0001-8532-7894","observed_orcids":["https://orcid.org/0000-0001-8532-7894"]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"A Meijer","raw_affiliation_strings":["Utrecht University School of Governance Utrecht University, Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Utrecht University School of Governance Utrecht University, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I193662353"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038693465","display_name":"Huub Schellekens","orcid":"https://orcid.org/0000-0002-8503-3965","observed_orcids":["https://orcid.org/0000-0002-8503-3965"]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"H Schellekens","raw_affiliation_strings":["Departments of Pharmaceutical Sciences and Innovation Studies, Utrecht University, Utrecht, The Netherlands","Innovation Studies Group Utrecht University, Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Pharmaceutical Sciences and Innovation Studies, Utrecht University, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I193662353"]},{"raw_affiliation_string":"Innovation Studies Group Utrecht University, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I193662353"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I193662353"],"apc_list":{"value":4410,"currency":"USD","value_usd":4410},"apc_paid":null,"fwci":6.0113,"has_fulltext":true,"cited_by_count":58,"citation_normalized_percentile":{"value":0.95679477,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"88","issue":"6","first_page":"848","last_page":"853"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.8539999723434448,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.8539999723434448,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13417","display_name":"Biomedical Ethics and Regulation","score":0.08489999920129776,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14396","display_name":"Healthcare Regulation","score":0.025100000202655792,"subfield":{"id":"https://openalex.org/subfields/3605","display_name":"Health Information Management"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/conditional-approval","display_name":"conditional approval","score":0.9860000014305115},{"id":"https://openalex.org/keywords/drug-regulation","display_name":"drug regulation","score":0.5299999713897705},{"id":"https://openalex.org/keywords/pharmaceutical-innovation","display_name":"pharmaceutical innovation","score":0.5590000152587891},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.8799999952316284},{"id":"https://openalex.org/keywords/risk-benefit-assessment","display_name":"risk-benefit assessment","score":0.8820000290870667},{"id":"https://openalex.org/keywords/regulatory-pathways","display_name":"regulatory pathways","score":0.6000000238418579}],"concepts":[{"id":"https://openalex.org/C2992293740","wikidata":"https://www.wikidata.org/wiki/Q4781752","display_name":"Drug approval","level":3,"score":0.6552323698997498},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.6205295324325562},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.5890015363693237},{"id":"https://openalex.org/C2910001868","wikidata":"https://www.wikidata.org/wiki/Q458","display_name":"European union","level":2,"score":0.5201466679573059},{"id":"https://openalex.org/C2778496695","wikidata":"https://www.wikidata.org/wiki/Q254128","display_name":"Dilemma","level":2,"score":0.5025386810302734},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.483832985162735},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4482017159461975},{"id":"https://openalex.org/C2777481183","wikidata":"https://www.wikidata.org/wiki/Q6770787","display_name":"Market access","level":3,"score":0.4288109838962555},{"id":"https://openalex.org/C100001284","wikidata":"https://www.wikidata.org/wiki/Q2248246","display_name":"Public economics","level":1,"score":0.42012810707092285},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.365975022315979},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.34040340781211853},{"id":"https://openalex.org/C155202549","wikidata":"https://www.wikidata.org/wiki/Q178803","display_name":"International trade","level":1,"score":0.1768311858177185},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.1667037308216095},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.0},{"id":"https://openalex.org/C111472728","wikidata":"https://www.wikidata.org/wiki/Q9471","display_name":"Epistemology","level":1,"score":0.0},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0},{"id":"https://openalex.org/C118518473","wikidata":"https://www.wikidata.org/wiki/Q11451","display_name":"Agriculture","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005060","descriptor_name":"Europe","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005062","descriptor_name":"European Union","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":true},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":6,"locations":[{"id":"doi:10.1038/clpt.2010.207","doi":"https://doi.org/10.1038/clpt.2010.207","is_oa":true,"landing_page_url":"https://doi.org/10.1038/clpt.2010.207","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/clpt.2010.207","source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology &amp; Therapeutics","raw_type":"journal-article"},{"id":"pmid:20962774","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20962774","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Comparative Study"},{"id":"pmh:oai:dspace.library.uu.nl:1874/191117","doi":null,"is_oa":false,"landing_page_url":"http://dspace.library.uu.nl:8080/handle/1874/191117","pdf_url":null,"source":{"id":"https://openalex.org/S4306401649","display_name":"Utrecht University Repository (Utrecht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I193662353","host_organization_name":"Utrecht University","host_organization_lineage":["https://openalex.org/I193662353"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"},{"id":"pmh:oai:dspace.library.uu.nl:1874/385534","doi":null,"is_oa":true,"landing_page_url":"https://dspace.library.uu.nl/handle/1874/385534","pdf_url":null,"source":{"id":"https://openalex.org/S4306401649","display_name":"Utrecht University Repository (Utrecht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I193662353","host_organization_name":"Utrecht University","host_organization_lineage":["https://openalex.org/I193662353"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"},{"id":"pmh:uu:oai:dspace.library.uu.nl:1874/191117","doi":null,"is_oa":false,"landing_page_url":"https://dspace.library.uu.nl/handle/1874/191117","pdf_url":null,"source":{"id":"https://openalex.org/S4306401649","display_name":"Utrecht University Repository (Utrecht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I193662353","host_organization_name":"Utrecht University","host_organization_lineage":["https://openalex.org/I193662353"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clinical Pharmacology and Therapeutics, 88(6), 848. Nature Publishing Group","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:uu:oai:dspace.library.uu.nl:1874/385534","doi":null,"is_oa":true,"landing_page_url":"https://dspace.library.uu.nl/handle/1874/385534","pdf_url":null,"source":{"id":"https://openalex.org/S4306401649","display_name":"Utrecht University Repository (Utrecht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I193662353","host_organization_name":"Utrecht University","host_organization_lineage":["https://openalex.org/I193662353"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clinical Pharmacology and Therapeutics, 88(6), 848. Nature Publishing Group","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1038/clpt.2010.207","doi":"https://doi.org/10.1038/clpt.2010.207","is_oa":true,"landing_page_url":"https://doi.org/10.1038/clpt.2010.207","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/clpt.2010.207","source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology &amp; Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8560000061988831}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320321800","display_name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","ror":"https://ror.org/04jsz6e67"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2017441286.pdf","grobid_xml":"https://content.openalex.org/works/W2017441286.grobid-xml"},"referenced_works_count":12,"referenced_works":["https://openalex.org/W1964166318","https://openalex.org/W2007025787","https://openalex.org/W2033000192","https://openalex.org/W2040163475","https://openalex.org/W2046254512","https://openalex.org/W2056014776","https://openalex.org/W2067460372","https://openalex.org/W2069541474","https://openalex.org/W2075375284","https://openalex.org/W2082457815","https://openalex.org/W2106723663","https://openalex.org/W2157584018"],"related_works":["https://openalex.org/W1864298660","https://openalex.org/W7007712965","https://openalex.org/W7151431054","https://openalex.org/W2523669501","https://openalex.org/W2906556128","https://openalex.org/W3111418192","https://openalex.org/W6977482220","https://openalex.org/W2747639583","https://openalex.org/W7130644434","https://openalex.org/W4376121338"],"abstract_inverted_index":{"The":[0,30],"need":[1],"for":[2,10,16,86,116],"fast":[3],"drug":[4],"innovation":[5],"and":[6,45,63],"the":[7,58,83,90,94,123,132],"public":[8],"demand":[9],"risk-free":[11],"drugs":[12,62,118],"creates":[13],"a":[14],"dilemma":[15],"regulatory":[17,80,110],"authorities:":[18],"less":[19,126],"restrictive":[20],"procedures":[21],"involve":[22],"uncertainties":[23],"about":[24],"benefit/risk":[25],"profiles":[26],"of":[27,60,78],"new":[28,61],"drugs.":[29,72,88],"European":[31],"Union":[32],"has":[33],"introduced":[34],"two":[35],"instruments":[36,56],"that":[37,76,134],"regulate":[38],"early":[39],"market":[40,124],"access:":[41],"conditional":[42],"approvals":[43,46,137],"(CAs)":[44],"under":[47,99],"exceptional":[48],"circumstances":[49],"(ECs).":[50],"We":[51],"have":[52],"studied":[53],"whether":[54,64],"these":[55,79,135,153],"compromise":[57],"safety":[59,142,148],"they":[65],"lead":[66],"to":[67,70,119],"earlier":[68],"access":[69],"innovative":[71,87],"Our":[73],"study":[74],"shows":[75],"neither":[77],"pathways":[81],"accelerates":[82],"approval":[84],"process":[85],"However,":[89],"CA":[91],"pathway":[92,111],"shortens":[93],"clinical":[95,105],"development":[96,106],"period.":[97],"Approvals":[98],"ECs":[100],"are":[101,129,138,145],"associated":[102,150],"with":[103,151],"longer":[104],"periods,":[107],"but":[108],"this":[109],"may":[112],"open":[113],"up":[114],"opportunities":[115],"specific":[117],"be":[120],"admitted":[121],"into":[122],"because":[125],"comprehensive":[127],"data":[128],"required.":[130],"Despite":[131],"fact":[133],"advanced":[136],"based":[139],"on":[140],"limited":[141],"databases,":[143],"there":[144],"no":[146],"special":[147],"issues":[149],"using":[152],"pathways.":[154]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":5},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}
